DAS-6-2-2-6-CRBN effectively reduced the viability of BCR-ABL-dependent K562 CML cells with an EC50 of 4.4 nM [78]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.